Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Bobby Tingstedt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5940-8276; OpenAlex author ID A5038125048. Sources: OpenAlex.

Their work

Papers
15 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
62
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: 2 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 4 papers · 2025: 1 paper · 2026: 1 paper

Papers 15

  1. Multiple R1 margins are associated with shorter overall survival: national register-based study on pancreatic cancer. Co-author DOI 10.1093/bjsopen/zrag155↗
  2. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Co-author DOI 10.1016/j.annonc.2024.12.015↗
  3. Surveillance after surgery for pancreatic cancer: a global scoping review of guidelines and a nordic Survey of contemporary practice. Co-author DOI 10.1080/00365521.2024.2378948↗
  4. Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis. Co-author DOI 10.1097/xcs.0000000000000971↗
  5. Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Eval… Co-author DOI 10.1245/s10434-024-15932-3↗
  6. ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Pa… Co-author DOI 10.1245/s10434-024-16021-1↗
  7. Neoadjuvant chemo(radio)therapy in upfront resectable pancreatic cancer - can we stratify patients better in the future? First author DOI 10.1080/00365521.2022.2100226↗
  8. Risk factors and outcomes for patients with pancreatic cancer undergoing surgical exploration without resection due to metastatic disease: A national cohort st… Co-author DOI 10.1016/j.hbpd.2022.02.003↗
  9. Targeting dendritic cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12935-018-0585-0↗
  10. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. Co-author DOI 10.1016/j.hpb.2017.06.010↗
  11. Pancreatic cancer: yesterday, today and tomorrow. First author DOI 10.2217/fon-2016-0010↗
  12. Artificial neural networks predict survival from pancreatic cancer after radical surgery. Co-author DOI 10.1016/j.amjsurg.2012.05.032↗
  13. Pancreatic cancer - cost for overtreatment with gemcitabine. First author DOI 10.3109/0284186x.2012.744140↗
  14. Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach. Co-author DOI 10.1007/s00268-011-1208-2↗
  15. Early onset pancreatic cancer: a controlled trial. Co-author PMID 24713777↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bodil Andersson · 7 shared papers, 2013–2024 · strength 0.94
  2. Roland E. Andersson · 8 shared papers, 2011–2024 · strength 0.88
  3. Poya Ghorbani · 3 shared papers, 2024–2026 · strength 0.66
  4. Bergþór Björnsson · 4 shared papers, 2024 · strength 0.64
  5. Marc G. Besselink · 4 shared papers, 2017–2024 · strength 0.53
  6. Ernesto Sparrelid · 2 shared papers, 2024–2026 · strength 0.52
  7. Karin U. Johansen · 3 shared papers, 2024 · strength 0.48
  8. Tobias Keck · 3 shared papers, 2024 · strength 0.48
  9. Simone Augustinus · 3 shared papers, 2024 · strength 0.48
  10. Ulrich Friedrich Wellner · 3 shared papers, 2024 · strength 0.48
  11. Henry Anthony Pitt · 3 shared papers, 2024 · strength 0.48
  12. Daniel Ansari · 5 shared papers, 2013–2024 · strength 0.42
  13. Carlos Fernández Moro · 1 shared paper, 2026 · strength 0.36
  14. Patrik Larsson · 1 shared paper, 2026 · strength 0.36
  15. Melroy Alistair D'souza · 1 shared paper, 2026 · strength 0.36
  16. Izaak Quintus Molenaar · 3 shared papers, 2017–2024 · strength 0.35
  17. Christopher Lee Wolfgang · 3 shared papers, 2017–2024 · strength 0.35
  18. Matthew H. G. Katz · 2 shared papers, 2024 · strength 0.31
  19. Michael B. Ghadimi · 2 shared papers, 2024 · strength 0.31
  20. Michael Garrett House · 2 shared papers, 2024 · strength 0.31
  21. Susan van Dieren · 2 shared papers, 2024 · strength 0.31
  22. Tara M. Mackay · 2 shared papers, 2024 · strength 0.31
  23. Waldemar H. Uhl · 2 shared papers, 2024 · strength 0.31
  24. Thomas F. Stoop · 2 shared papers, 2024 · strength 0.31
  25. Roeland F. de Wilde · 2 shared papers, 2024 · strength 0.31

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.